General Mills’ Pet Segment Performs Well

Image Source: General Mills Inc – Second Quarter Fiscal 2020 Earnings IR Presentation By Callum Turcan On December 18, General Mills Inc (GIS) reported second quarter results for its fiscal 2020 (period ended November 24, 2019), which saw shares of GIS rise by almost 2% during normal trading hours that day as investors were excited over its strong performance of its pet food sales. Please note General Mills completed its $8.0 billion all-cash acquisition of Blue Buffalo Pet Products Inc in April 2018, and investors have been eagerly awaiting the revenue growth stimulus that deal was projected to generate. Shares of GIS are trading near the very top of our fair value range estimate and yield 3.7% as of this … Read more

Smucker Cuts Guidance with Weakness Widespread

Image Source: J. M. Smucker Company – IR Presentation By Callum Turcan J. M. Smucker Company (SJM) is known for its peanut butter (sold under such brands as Jif and Adams), jams (including its namesake Smucker’s offering and Knott’s Berry Farm products), coffees (such as Folgers and Café Bustelo), pet products (including Nature’s Recipe and Meow Mix), and more. The firm posted first quarter earnings for FY2020 (quarter ended July 31) on August 27 that upset the market and sent shares down more than 8% that day. Smucker’s revenue and earnings both missed estimates while management lowered the firm’s full year guidance for fiscal 2020. Smucker now expects its FY2020 EPS to come in at $8.35-$8.55/share, down from $8.45-$8.65/share previously. … Read more

Elanco Buys Bayer’s Animal Health Unit, Gaining Scale and Greater Exposure to the Humanization of Pets” Trend”

Image Shown: Shares of Elanco Animal Health Inc (ELAN) sold off after the company announced on August 20 it was acquiring Bayer AG’s (BAYRY) animal health unit through a cash and deal stock deal worth $7.6 billion at the time the deal was announced. By Callum Turcan On August 20, Elanco Animal Health Inc (ELAN) agreed to acquire Bayer AG’s (BAYRY) animal health unit for $7.6 billion (at the time the deal was announced) through a cash and stock deal. That includes $5.3 billion in cash and $2.3 billion in stock, keeping in mind shares of ELAN initially shifted lower after the news. Bayer plans to exit its stake in Elanco over time as management seeks to rebuild the company’s … Read more